Biomarkers in whichever modality are tremendously important in diagnosing of disease,
tracking disease progression and clinical trials. This applies in particular for disorders with a …

Abstract The Electrophysiology Professional Interest Area (EPIA) and Global Brain
Consortium endorsed recommendations on candidate electroencephalography (EEG) …

Parkinson's disease presents several practical challenges: it can be difficult to distinguish
from atypical parkinsonian syndromes, clinical ratings can be insensitive as markers of …

We studied the dynamic functional connectivity profile of dementia with Lewy bodies (DLB)
and Alzheimer's disease (AD) compared to controls, how it differs between the two dementia …

Background Subjective cognitive decline (SCD) is a preclinical stage along the Alzheimer's
disease (AD) continuum. However, little is known about the aberrant patterns of connectivity …

Genetic studies in late-onset Alzheimer disease (LOAD) are aimed at identifying core
disease mechanisms and providing potential biomarkers and drug candidates to improve …

Graph theoretical approach has proved an effective tool to understand, characterize, and
quantify the complex brain network. However, much less attention has been paid to methods …

Studies on dementia with Lewy bodies (DLB) have mainly focused on the degeneration of
distinct cortical and subcortical regions related to the deposition of Lewy bodies. In view of …

Background Resting-state functional MRI has been proposed as a new biomarker of
prodromal neurodegenerative disorders, but it has been poorly investigated in the idiopathic …

Transcranial alternating current stimulation (tACS) is a promising tool for modulating brain
oscillations. Combining tACS with functional magnetic resonance imaging (fMRI), we …